Last quarter (Q3 2023), Ultragenyx Pharmaceutical's total revenue was $98.05M, an increase of 8.10% from the same quarter last year. In Q3, Ultragenyx Pharmaceutical's net income was $-120.01M. See Ultragenyx Pharmaceutical’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ 348.23M	$ 363.33M	$ 351.41M	$ 271.03M	$ 103.71M	$ 51.49M
Cost of Revenue	$ 43.02M	-	-	$ 6.13M	$ 9.01M	$ 1.15M
Gross Profit	$ 367.19M	$ 363.33M	$ 351.41M	$ 264.90M	$ 94.71M	$ 50.35M
Operating Expense	$ 964.19M	$ 955.61M	$ 762.57M	$ 595.02M	$ 518.88M	$ 421.72M
Operating Income	$ -618.97M	$ -648.92M	$ -411.16M	$ -330.12M	$ -424.17M	$ -371.37M
Net Non Operating Interest Income Expense	$ 24.33M	$ 11.07M	$ 1.93M	$ -26.25M	$ 12.10M	$ 9.54M
Other Income Expense	$ 1.85M	$ 20.86M	$ 43.75M	$ 171.01M	$ 12.63M	$ 164.73M
Pretax Income	$ -649.36M	$ -701.73M	$ -452.98M	$ -185.36M	$ -399.44M	$ -197.10M
Tax Provision	$ 426.00K	$ 5.70M	$ 1.04M	$ 1.21M	$ 3.28M	$ 514.00K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -595.64M	$ -607.77M	$ -454.02M	$ -186.57M	$ -402.73M	$ -197.61M
Basic EPS	-	-	-	$ -3.07	$ -7.12	$ -3.97
Diluted EPS	-	-	-	$ -3.07	$ -7.12	$ -3.97
Basic Average Shares	-	-	-	$ 60.85M	$ 56.58M	$ 49.78M
Diluted Average Shares	-	-	-	$ 60.85M	$ 56.58M	$ 49.78M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 1.01B	$ 955.61M	$ 762.57M	$ 601.15M	$ 527.89M	$ 422.87M
Net Income From Continuing And Discontinued Operation	$ -635.28M	$ -707.42M	$ -454.02M	$ -186.57M	$ -402.73M	$ -197.61M
Normalized Income	$ -125.61M	$ -554.36M	-	$ -310.96M	$ -412.52M	$ -321.95M
Interest Expense	-	-	-	$ 33.29M	$ 1.14M	$ 0.00
EBIT	$ -655.56M	$ -701.69M	$ 0.00	$ -152.07M	$ -398.31M	$ -197.10M
EBITDA	$ -498.23M	$ -680.77M	$ 0.00	$ -139.81M	$ -389.77M	$ -177.56M

Currency in USD

Ultragenyx Pharmaceutical Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing